Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls

T-cell replete Haploidentical stem cell transplantation (Haplo-SCT) with Post-transplant cyclophosphamide (PT-Cy) is an emerging therapeutic option for patients with advanced relapsed or refractory lymphoma. The feasibility of this platform is supported by several retrospective studies showing a tox...

Full description

Bibliographic Details
Main Authors: Jacopo Mariotti, Stefania Bramanti, Armando Santoro, Luca Castagna
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/11/3589